Columbia
New York State Awards $3M to Researchers for Infectious Disease Tool Innovations
Teams from Rover Diagnostics, Mount Sinai, Columbia University, and Niagara University are the third round of awardees of the state’s Biodefense Commercialization Fund.
At the inaugural International Conference on Newborn Sequencing (ICoNS) in Boston last week, researchers outlined plans from eight studies in the US, the UK, Europe, and Australia.
The public-private partnership will initially screen babies for up to about 250 rare genetic conditions, most of which are not included in standard newborn screening.
Sema4's GeneDx to Provide Genome Sequencing, Interpretation for Large-Scale Newborn Screening Study
The GUARDIAN (Genomic Uniform-screening Against Rare Diseases in All Newborns) study plans to screen 100,000 newborns for up to 250 rare genetic conditions.
New York City Opening Dedicated COVID-19 Testing Laboratory
The Manhattan-based lab will scale its capacity to process 20,000 tests per day by November and provide results dedicated to the city.